867 related articles for article (PubMed ID: 30550238)
1. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
Michno M; Sydor A; Wałaszek M; Sułowicz W
Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents].
Kot B; Wicha J; Zak-Puławska Z
Przegl Epidemiol; 2010; 64(2):307-12. PubMed ID: 20731243
[TBL] [Abstract][Full Text] [Related]
4. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
Marković T; Jeinić L; Smitran A; Petković M
Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
[TBL] [Abstract][Full Text] [Related]
7. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
Bonkat G; Müller G; Braissant O; Frei R; Tschudin-Suter S; Rieken M; Wyler S; Gasser TC; Bachmann A; Widmer AF
World J Urol; 2013 Dec; 31(6):1427-32. PubMed ID: 23358791
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
Roldan-Masedo E; Sainz T; Gutierrez-Arroyo A; Gomez-Gil RM; Ballesteros E; Escosa L; Baquero-Artigao F; Méndez-Echevarría A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2097-2102. PubMed ID: 31359255
[TBL] [Abstract][Full Text] [Related]
9. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
10. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
Bischoff S; Walter T; Gerigk M; Ebert M; Vogelmann R
BMC Infect Dis; 2018 Jan; 18(1):56. PubMed ID: 29373965
[TBL] [Abstract][Full Text] [Related]
11. Etiology and Antibiotic Susceptibility Patterns of Urinary Tract Infections in Children in a General Hospital in Kuwait: A 5-Year Retrospective Study.
Al Benwan K; Jamal W
Med Princ Pract; 2022; 31(6):562-569. PubMed ID: 36310010
[TBL] [Abstract][Full Text] [Related]
12. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
[TBL] [Abstract][Full Text] [Related]
13. Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Mumtaz K; Munir S; Muddassir M; Raza A; Waqas K; Shoaib Ahmed S; Malik A; Haider Naqvi SZ
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1111-1118. PubMed ID: 34602440
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of antimicrobial susceptibility of Escherichia coli producing urinary tract infections in Galicia (Spain)].
Treviño M; Losada I; Fernández-Pérez B; Coira A; Peña-Rodríguez MF; Hervada X;
Rev Esp Quimioter; 2016 Apr; 29(2):86-90. PubMed ID: 26964515
[TBL] [Abstract][Full Text] [Related]
15. Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing
Al-Tamimi M; Abu-Raideh J; Albalawi H; Shalabi M; Saleh S
Microb Drug Resist; 2019 Oct; 25(8):1132-1141. PubMed ID: 31107146
[No Abstract] [Full Text] [Related]
16. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Jalil MB; Al Atbee MYN
J Clin Lab Anal; 2022 Sep; 36(9):e24619. PubMed ID: 35870190
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Lu PL; Liu YC; Toh HS; Lee YL; Liu YM; Ho CM; Huang CC; Liu CE; Ko WC; Wang JH; Tang HJ; Yu KW; Chen YS; Chuang YC; Xu Y; Ni Y; Chen YH; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S37-43. PubMed ID: 22749057
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli and Klebsiella pneumoniae Sensitivity/Resistance Pattern Towards Antimicrobial Agents in Primary and Simple Urinary Tract Infection Patients Visiting University Hospital of Jamia Hamdard New Delhi.
Rizwan M; Akhtar M; Najmi AK; Singh K
Drug Res (Stuttg); 2018 Jul; 68(7):415-420. PubMed ID: 29529677
[TBL] [Abstract][Full Text] [Related]
20. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
